Paul Tudor Jones’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
3,200
+1,000
+45% +$371K ﹤0.01% 2256
2026
Q1
$644K Sell
2,200
-23,200
-91% -$7.62M ﹤0.01% 2654
2025
Q4
$8.9M Sell
25,400
-114,600
-82% -$38.7M 0.02% 815
2025
Q3
$45.2M Buy
140,000
+115,600
+474% +$36M 0.08% 190
2025
Q2
$9.49M Buy
24,400
+15,400
+171% +$6.19M 0.02% 692
2025
Q1
$3.91M Buy
9,000
+1,900
+27% +$763K 0.01% 912
2024
Q4
$2.62M Buy
7,100
+5,000
+238% +$2.09M 0.01% 1068
2024
Q3
$1.09M Buy
+2,100
New +$1.12M ﹤0.01% 1561
2024
Q2
Sell
-2,800
Closed -$1.45M 2436
2024
Q1
$1.45M Sell
2,800
-1,200
-30% -$597K 0.01% 1173
2023
Q4
$1.89M Buy
4,000
+2,800
+233% +$1.29M 0.02% 1127
2023
Q3
$523K Sell
1,200
-1,600
-57% -$726K 0.01% 1658
2023
Q2
$1.24M Buy
+2,800
New +$1.29M 0.01% 1186
2022
Q4
Sell
-2,800
Closed -$1.27M 2500
2022
Q3
$1.27M Sell
2,800
-1,900
-40% -$909K 0.03% 767
2022
Q2
$2.27M Buy
4,700
+1,600
+52% +$792K 0.06% 455
2022
Q1
$1.52M Buy
3,100
+500
+19% +$229K 0.04% 681
2021
Q4
$1.2M Sell
2,600
-2,400
-48% -$1.01M 0.02% 901
2021
Q3
$1.86M Buy
+5,000
New +$1.9M 0.03% 759

Other funds holding ELV

Paul Tudor Jones's ELV Position: Q2 2026 in Review

Paul Tudor Jones sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 25,499 shares — an estimated $9.46M sold.

Paul Tudor Jones first reported a position in ELV in Q2 2013 and held it in 37 quarters. The position peaked at $25.1M in Q3 2025. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Paul Tudor Jones reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 25,499 Elevance Health shares in Q2 2026, an estimated $9.46M.
  • Paul Tudor Jones first reported a position in Elevance Health in Q2 2013 and held it in 37 quarters.
  • Paul Tudor Jones's Elevance Health position peaked at $25.1M in Q3 2025.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.